Cancer Claim at the heart of the Belviq Lawsuit
Numerous cancer claim lawsuits are being filed against Belviq, a prescription weight loss drug that was approved by the FDA in 2012. In February 2020, the Food and Drug Administration required the manufacturer of Belviq, Eisai Inc., to remove the drug from the market due to concerns about an increased risk of cancer in patients taking the pharmaceutical.
Lawsuits involving a cancer claim have been filed against Eisai Inc. by patients who took either Belviq or Belviq XR. These lawsuits allege that the company failed to adequately warn patients about the potential risks of the drug, including the risk of cancer.
In their cancer claim, plaintiffs argue that if they had known about the increased risk of cancer associated with Belviq, they would not have taken the drug, or would have taken it for a shorter period of time. They are seeking compensation for medical expenses, lost income, and other damages.
Lawsuits Against Eisai Inc. Ongoing
It’s important to note that these lawsuits are still ongoing, and the outcome is not yet determined. The results of the lawsuits will depend on a variety of factors, including the strength of the evidence linking Belviq to an increased risk of cancer and the specific facts of each case.
What Cancers Have Been Associated With Taking Belviq?
The increased cancer risk was identified in a clinical trial that followed patients for an average of nearly five years. The trial showed that patients who took Belviq had a higher rate of certain types of cancer, including lung, colorectal, and pancreatic, compared to patients who did not take the drug.
It’s important to note that the increased risk of cancer associated with Belviq is still being studied and more research is needed to fully understand the extent of the risk due to these defective drugs. The FDA’s decision to remove Belviq from the market was based on its determination that the potential risks of the drug outweigh the benefits for patients.
Determining Your Risk of Cancer From Taking Belviq
If you have taken Belviq and are concerned about the potential risk of cancer, it’s important to speak with your doctor. They can evaluate your individual medical history and health status to determine if there is a potential risk to your health and suggest appropriate next steps.
Consulting With a Defective Drug Lawyer
If you or someone you know has taken Belviq and been diagnosed with cancer, it may be worth consulting with a personal injury attorney to learn more about your legal rights and options. A defective drug lawyer can review your case and help you file a cancer claim to recover the cost of medical expenses, wages and the compensation you deserve for your pain and suffering.
Olinde Law Firm: Defective Drug Lawyers
We at the Olinde Law Firm will work tirelessly to obtain the compensation you deserve whether you were injured by a pharmaceutical product or lost a loved one to a defective drug or cancer caused by their medication. Our pharmaceutical litigation attorneys provide free consultations to people who have been injured by defective drugs. To get started, please call (504) 587-1440 in New Orleans or (800) 587-1889 if you are calling long-distance. We also offer an online contact form.